Trials / Unknown
UnknownNCT04685460
3D Printed Bolus in Post-mastectomy Radiotherapy
Clinical Study of 3D Printed Bolus for Volumetric Modulated Arc Therapy of Post-mastectomy Treatment
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 70 (estimated)
- Sponsor
- Jiangxi Provincial Cancer Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Recently, there is growing interest in the application of three-dimensional (3D) printed bolus to radiotherapy.At present, the researches on the application of 3D-printed bolus in breast cancer are mainly focused on air gap between skin and bolus or electron beam conformal therapy \[7,15\], there are no clinical experience with customized 3D-printed bolus for volumetric modulated arc therapy (VMAT) in daily practice has been published up to now. We aim to evaluate dosimetry and application of 3D-printed bolus for the post-mastectomy radiotherapy (PMRT) with Volumetric modulated arc therapy (VMAT). Seventy five patients with breast cancer receiving radiotherapy following post-mastectomy in our department were randomly selected in this study. The accuracy of fit of the 3D-Printed bolus to the chest wall was improved significantly relative to conventional bolus.This study demonstrates customized 3D-printed bolus in post-mastectomy radiation therapy improves fit of the bolus compared to conventional bolus. Furthermore, VMAT based on 3D-printed bolus significantly improves the chest wall target coverage and the conformity of plan, and reduces the dose of ipsilateral lung and heart, compared to conventional bolus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images | customized 3D-printed bolus fabricated based on reconstruction of computed tomography (CT) images were used in this study. |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2021-04-15
- Completion
- 2021-04-20
- First posted
- 2020-12-28
- Last updated
- 2021-04-19
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04685460. Inclusion in this directory is not an endorsement.